Not Approved (US)

Thymosin Alpha-1

Thymic peptide (immune-modulating)

This page is educational only and is not medical advice. It is not an endorsement to use this compound. See the Educational Disclaimer for details.

What It Is

A naturally occurring peptide derived from the thymus gland, studied for immune-modulating properties. Sold in some countries as an approved pharmaceutical product (brand name Zadaxin) — its regulatory status differs meaningfully between the US and other countries, which content must always specify.

Proposed Mechanism

Proposed to modulate T-cell function and broader immune response, based on its role in normal thymic immune signaling.

Areas Researchers Are Investigating

Adjunctive use in certain infectious disease contexts (studied more outside the US)
Immune response modulation in various clinical research contexts
Vaccine-adjuvant-related research (early-stage)

Human Evidence

Moderate — clinical studies exist internationally (particularly in countries where it's an approved product for specific indications such as chronic hepatitis B/C), but the US regulatory picture is different, and evidence quality/scale varies significantly by study and country; this must be characterized precisely rather than summarized as one uniform "human evidence" tier.

Animal / Preclinical Evidence

Immune-pharmacology research characterizing its mechanism preceded and accompanied the international clinical studies.

Current FDA / Regulatory Status

Not FDA-approved in the United States. Approved in some other countries (under the brand name Zadaxin) for specific indications. In the US it is generally available only as a compounded product, which carries a different (and less rigorously reviewed) regulatory status than an FDA-approved drug — this distinction must be made explicit in any content.

Known Safety Information

Reasonably well-characterized in countries where it's an approved product, per those regulatory bodies' data — but that does not equate to FDA review or approval, and content should not imply otherwise.

Limitations of Evidence

Evidence quality and applicability varies by country/study; US-specific compounded-product safety and quality is a distinct question from the approved-product data used internationally.

Key studies and full references for this entry are still being compiled and verified — see data/peptides/thymosin-alpha-1.md in the project repo for the current compliance-review status. This page will not publish claims backed by unverified or fabricated citations.